Pharmaceuticals, Biotechnology and Life Sciences
DUBLIN–(BUSINESS WIRE)–The “Global Post-Herpetic Neuralgia Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…
DUBLIN–(BUSINESS WIRE)–The “Global Vasculitis Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides most…
DUBLIN–(BUSINESS WIRE)–The “Global Prader-Willi Syndrome Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…
– ULTOMIRIS demonstrated consistent efficacy and safety through 52 weeks, with no cases of breakthrough hemolysis (BTH) associated with incomplete…
DUBLIN–(BUSINESS WIRE)–The “Pancreatitis – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…
DUBLIN–(BUSINESS WIRE)–The “Gonorrhea – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…
DUBLIN–(BUSINESS WIRE)–The “Zika Virus – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report…
DUBLIN–(BUSINESS WIRE)–The “Liver Transplantation – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report…
DUBLIN–(BUSINESS WIRE)–The “Hyperparathyroidism – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This report provides…
DUBLIN–(BUSINESS WIRE)–The “Female Sexual Dysfunction – Global Clinical Trial Pipeline Highlights, 2019” report has been added to ResearchAndMarkets.com’s offering. This…